{"nct_id":"NCT00819780","title":"PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors","status":"COMPLETED","status_verified_date":"2022-11","start_date":"2009-04-24","start_date_type":"ACTUAL","primary_completion_date":"2012-05-30","primary_completion_date_type":"ACTUAL","completion_date":"2016-07-07","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AMGN"]}